000			01943nam a2200409 i 4500
999			_c280354 _d280354
001			ocn680493853
003			OCoLC
005			20190424101445.0
006			m o d f
007			cr bn||||a||||
008			101110s1999 dcu ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCO _dOCLCQ _dCWCLL _dNJR _dBUF _dOCLCQ _dOCLCF _dUWO _dOCLCQ _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:106-7
088			_aSerial no. 106-7 (United States. Congress. House. Committee on Commerce)
099			_aY 4.C 73/8:106-7
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Commerce. _bSubcommittee on Oversight and Investigations,
245	1	0	_aDate rape drugs : _bhearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives ; One Hundred Sixth Congress, first session ; March 11, 1999.
264		1	_aWashington : _bU.S. Government Printing Office, _c1999.
300			_a1 online resource (iii, 102 pages)
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial no. 106-7."
500			_aCRDP Program record.
504			_aIncludes bibliographical references (pages 95-96).
588			_aDescription based on online resource, PDF version; title from title page (govinfo, viewed Mar. 15, 2019).
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. _tDate rape drugs _w(DLC) 99489515 _w(OCoLC)41629691
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo117584
650		0	_aDate rape drugs _zUnited States.
650		0	_aGamma-hydroxybutyrate _xGovernment policy _zUnited States.
650		0	_aKetamine _xGovernment policy _zUnited States.
650		0	_aDrugs of abuse _xGovernment policy _zUnited States.
942			_2sudocs _c8